Spissinger Allan Horst 4
4 · Lexaria Bioscience Corp. · Filed Feb 15, 2019
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
common shares
2019-02-15$0.37/sh+50,000$18,500→ 119,116 total - Exercise/Conversion
Stock Options
2019-02-15$0.37/sh−50,000$18,500→ 650,000 totalExercise: $0.37From: 2017-06-01Exp: 2022-06-01→ Common Shares (50,000 underlying)
Holdings
- 700,000
Stock Options
Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ Common Shares (300,000 underlying) - 69,166
common shares
- 200,000
Stock Options
Exercise: $0.37From: 2017-06-01Exp: 2022-06-01→ Common Shares (200,000 underlying) - 400,000
Stock Options
Exercise: $0.83From: 2017-12-01Exp: 2022-12-01→ Common Shares (200,000 underlying)